enVVeno Medical
NVNO
3 hedge funds and large institutions have $173K invested in enVVeno Medical in 2018 Q3 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.
50% more funds holding
Funds holding: 2 → 3 (+1)
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
0% more ownership
Funds ownership: 0% → 0% (+0%)
9% less capital invested
Capital invested by funds: $190K → $173K (-$17K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$139K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$27.8K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.31K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$127K |
| 2 |
Jane Street
New York
|
-$62K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $141K | +$139K | +60 | New |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $29K | +$27.8K | +12 | New |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $2K | +$2.31K | +1 | New |
|
|
WA
4
WealthTrust-Arizona
Scottsdale,
Arizona
| $1K | – | – | – |
|
|
5
Goldman Sachs
New York
| – | -$127K | -39 | Closed |
|
|
6
Jane Street
New York
| – | -$62K | -19 | Closed |
|
|
7
UBS Group
Zurich,
Switzerland
| – | -$1K | – | – |
|
NVNO Hedge Fund Activity: Q3 2018 in Review
3 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in enVVeno Medical (NVNO) for Q3 2018, worth a combined $173K — down 8.9% from $190K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new NVNO positions and 2 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Vanguard Group, opening a new position worth an estimated $139K. The largest seller was Goldman Sachs, exiting entirely with an estimated $127K sold.
- 3 institutional investors held enVVeno Medical (NVNO) as of Q3 2018, up from 2 in Q2 2018.
- Funds reported $173K of enVVeno Medical stock for Q3 2018, down 8.9% quarter-over-quarter.
- 3 funds opened new enVVeno Medical positions in Q3 2018 and 2 closed out, a net change of +1 holder.
- The largest enVVeno Medical buyer in Q3 2018 was Vanguard Group, an estimated $139K added.
- The largest enVVeno Medical seller in Q3 2018 was Goldman Sachs, an estimated $127K sold.
Based on aggregated 13F filings for Q3 2018.